The latest molecular reports have delivered quite a few insights to the processes that govern the development and progression of CLL, together with quite a few novel mutated genes clustered in several functional pathways. The CLL epigenome is reprogrammed in the modulation of regulatory regions that show up de novoSizeable discrepancies in simultan